Gilead Sciences
GILD
$109.38
Share price
0.53%
Change (1 day)
49.22%
Change (1 year)
Categories
Gilead Sciences (GILD) Fails to deliver data
Key failure to deliver metrics for Gilead Sciences:
- Last SEC data release: 2025-06-30
- Last 15 days FTD volume: $4.85 M
- Last 3 months FTD volume: $16.11 M
- Last year FTD volume: $16.11 M
A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.
Failures to deliver for Gilead Sciences (GILD) - 3 months history
Number of shares, 3 months chart
Biweekly Failures to deliver volume for Gilead Sciences (GILD) - since 2013
Volume in USD (price x number of shares), data since 2013Gilead Sciences (GILD) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2025 | $0.16 B | 18.14% |
| 2024 | $0.14 B | -47.1% |
| 2023 | $0.26 B | 0.63% |
| 2022 | $0.26 B | 97.85% |
| 2021 | $0.13 B | -41.09% |
| 2020 | $0.22 B | 93.47% |
| 2019 | $0.11 B | -83.14% |
| 2018 | $0.70 B | 537.75% |
| 2017 | $0.11 B | -73.45% |
| 2016 | $0.41 B | -10.96% |
| 2015 | $0.46 B | -44.68% |
| 2014 | $0.84 B | 249.24% |
| 2013 | $0.24 B |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3 months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Amgen AMGN | $21.56 M | $0.29 B | 🇺🇸 USA |
 Vertex Pharmaceuticals VRTX | $21.98 M | $73.33 M | 🇺🇸 USA |
 AbbVie ABBV | $25.73 M | $0.20 B | 🇺🇸 USA |
 Illumina ILMN | $3.15 M | $72.77 M | 🇺🇸 USA |
 Biogen BIIB | $8.78 M | $62.76 M | 🇺🇸 USA |
 Pfizer PFE | $26.37 M | $0.27 B | 🇺🇸 USA |
 Johnson & Johnson JNJ | $10.58 M | $0.12 B | 🇺🇸 USA |
 Eli Lilly LLY | $37.29 M | $0.20 B | 🇺🇸 USA |
 Merck MRK | $12.12 M | $0.17 B | 🇺🇸 USA |